Pharma & Life Sciences

We are leaders in pharma and life sciences. We work with clients across the pharma value chain and have helped them achieve better business outcomes by portfolio expansion, distribution optimization, partner identification, pricing support, and digitization. The global pharmaceutical industry is in great flux today.

The relationship between payers, patients and pharmaceutical companies is changing as ‘pay-for-performance’ and product bundling is gathering momentum. Rising pressure on innovation is coupled with risk-averse regulators seeking to minimize fiascos like OxyContin and Vioxx. Focus on preventive therapies is rising as is the incidence of chronic disease.

Geographies are becoming increasingly varied in terms of epidemiological factors, regulatory ecosystem, and affluence. This technical and dynamic playfield requires seasoned practitioners and we possess unparalleled resources for all your needs. We access several proprietary and restricted databases to provide top-notch service in accelerating your business growth.

What we do?

Control tower

An integrated orchestration and control tower capability can help improve supply chain performance and KPI tracking. We help companies in designing control tower and provide implementation plan to make the right commitment to customers, drive adherence to commitments and improve OTIF.

Accelerate Time to Market

We help companies to reduce the time to file and launch products by streamlining R&D processes and systems, aiding to improve the Revenue Realization Efficiency (RRE) of the new product development process and institutionalizing robust project execution frameworks.

Improving cost competitiveness

We deploy our cost reduction frameworks and levers to identify sustainable cost reduction opportunities and drive the realization of opportunities through a strong PMO. We accelerate benefits realization by driving the implementation of quick wins.

Transformation for growth

We identify and size key-value creation opportunities in line with the growth aspirations of the company. We support and drive rapid returns by helping implement quick wins and lead business transformation to unlock ambitious growth opportunities.

Case Studies

Market prioritization and launch strategy

We assisted the client identify priority markets in South East Asia for the launch of next generation H2-blocker treatment of gastric ulcers. Deriving learnings from the drug’s success in EU5 markets and deploying our propriety two-pronged priority framework, we were able to shortlist the most attractive markets.

sales-acceleration-for-a-major-pharma-player-in-metro-tier-i-cities

Sales acceleration for a major Pharma player in metro and Tier I cities

We estimated the client’s sales force efficiency in 10 metro and Tier I cities to identify gaps and enhance output per employee. We also benchmarked the client’s sales and marketing budget to identify whether lower sales resulted from a lack of resources or due to poor utilization of them

Oncology & critical care market assessment and global expansion strategy for generic Indian player

We studied the overall oncology & critical care market in India and the market captured by Indian players in key emerging geographies such as Thailand, Vietnam & Iraq. For our client, we estimated the current market share and growth potential up to FY24 across geographies and for the product portfolio of 11 key molecules

Identifying growth levers for offline retail and online sales for pharmacies

We analyzed our client’s performance across offline retail and online sales channel and derived their key strengths and potential focus areas. Through in-depth interviews with online customers, we established 3 key customer archetypes to assist our client in formulating strategies according to them. The elaborate SWOT analysis would aid our client save significant margins & revenues over the next 5 years

investment-bright-spots-in-the-herbal-ayurvedic-otc-landscape-in-india

Investment bright spots in the Herbal and Ayurvedic OTC landscape in India

A large PE investor was looking to create an attractive portfolio of companies in the OTC category. We assessed the Indian Herbal & Ayurvedic OTC market opportunity and benchmarked it against various international markets. Within the overall assessment, we mapped all the sub categories within the segment, the opportunity and size of prize, profit pools, competitive dynamics, distribution models, and the ability for existing players to reach to a market leadership position. Alongside, we adjudged